A patent review of MAT2a inhibitors (2018-2021).

Saved in:
Bibliographic Details
Title: A patent review of MAT2a inhibitors (2018-2021).
Authors: Atkinson SJ; Oncology R&D, AstraZeneca, Cambridge UK., Evans L; Oncology R&D, AstraZeneca, Cambridge UK., Scott JS; Oncology R&D, AstraZeneca, Cambridge UK.
Source: Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2022 Oct; Vol. 32 (10), pp. 1043-1053. Date of Electronic Publication: 2022 Sep 01.
Publication Type: Review; Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9516419 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7674 (Electronic) Linking ISSN: 13543776 NLM ISO Abbreviation: Expert Opin Ther Pat Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1744-7674
DOI:10.1080/13543776.2022.2119127